Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Philips successfully completes tender offer for BioTelemetry, Inc.
Royal PhilipsFebruary 9, 2021 GMT February 9, 2021
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has successfully completed its previously announced tender offer (the “Offer”) to purchase all outstanding shares of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote cardiac diagnostics and monitoring for USD 72.00 per share in cash. At 12:00 midnight, New York time, on February 9, 2021 (one minute after 11:59 P.M., New York time, on February 8, 2021), the Offer expired as scheduled and was not extended. Philips expects to complete the acquisition of BioTelemetry later today through a merger under Section 251(h) of the General Corporation Law of the State of Delaware.
(2)
WESTBURY, N.Y., Feb. 4, 2021 /PRNewswire/ Exantas Capital Corp. (NYSE: XAN) (the Company ), a real estate investment trust that is focused on originating, holding and managing commercial real estate mortgage loans and other commercial real estate-related debt investments, announced today that effective February 16, 2021, the Company will change its name to ACRES Commercial Realty Corp. Additionally, the Board of Directors approved a 3-for-1 reverse split of the Company s common stock.
Name Change
The Company s common stock and 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock ( preferred stock ) will continue to be listed on the New York Stock Exchange, and the Company anticipates that on February 17, 2021, its common stock will begin trading under the symbol ACR and its preferred stock will begin trading under the symbol ACR PrC. The new CUSIP number for the Company s common stock following the name change will be 00489Q102, and the new CUSIP
Share this article
Share this article
PARK CITY, Utah, Jan. 29, 2021 /PRNewswire/ DW Healthcare Partners V, L.P. ( DWHP ), announced today the expiration and final results of its previously announced cash tender offer (the Tender Offer ) to purchase all of the outstanding ordinary shares (the Tender Securities ) of Parnell Pharmaceuticals Holdings Ltd (OTC Pink Open Market: PARNF) ( Parnell ) at a price of U.S.$0.40 per share, net to the seller in cash without interest and less applicable withholding taxes. The Tender Offer expired at one minute after 11:59 p.m., New York City time on January 28, 2021 (the Expiration Time ).
The terms and conditions of the Tender Offer are described in the Offer to Purchase, dated December 21, 2020 ( Offer to Purchase ) and related Letter of Transmittal (the Letter of Transmittal ).
Share this article
Share this article
SAN FRANCISCO, Jan. 25, 2021 /PRNewswire/ Nebula Caravel Acquisition Corp. (Nasdaq: NEBCU) (the Company ) announced today that, commencing January 29, 2021, holders of the 27,500,000 units sold in the Company s initial public offering may elect to separately trade shares of the Company s Class A common stock and warrants included in the units. Class A common stock and warrants that are separated will trade on The Nasdaq Capital Market under the symbols NEBC and NEBCW , respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on The Nasdaq Capital Markets under the symbol NEBCU. Holders of units will need to have their brokers contact American Stock Transfer & Trust Company, the Company s transfer agent, in order to separate the units into shares of Class A common stock and warrants.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
DWHP Announces Extension of The Expiration Time of Its Tender Offer
January 22, 2021 GMT
PARK CITY, Utah, Jan. 21, 2021 /PRNewswire/ DW Healthcare Partners V, L.P. (“DWHP”), announced today that it is extending the expiration time of its previously announced cash tender offer (the “Tender Offer”) in the Offer to Purchase dated December 21, 2020 (“Offer to Purchase”) for all of the outstanding ordinary shares (the “Tender Securities”) of Parnell Pharmaceuticals Holdings Ltd (OTC Pink Open Market: PARNF) (“Parnell”) at a price of U.S.$0.40 per share, net to the seller in cash without interest and less applicable withholding taxes to 11:59 p.m., New York City time, on January 28, 2021 (the “New Expiration Time”).